Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells.
Human neuroblastoma cell lines comprise cellular counterparts of normal differentiation phenotypes arising from the developing neural crest Three distinct cell types have been isolated from cell lines: N-type cells with properties of embryonic sympathoadrenoblasts, S-type cells resembling nonneuronal Schwannian/glial/melanoblastic precursors, and I-type stem cells that can differentiate into either N- or S-type cells. Sympathoadrenoblasts from the normal neural crest further differentiate into neuronal or neuroendocrine cells. In this study, we show that malignant N-type neuroblasts likewise can differentiate futher along these same pathways. Retinoic acid and forskolin induce a neuronalphenotype, denoted morphologically by cell aggregation and increased neurite formation and biochemically by increases in neurofilament proteins, tyrosine hydroxylase, and secretogranin II and decrease inchromogranin A. By contrast, dexamethasone, a synthetic glucocorticoid, induces a chromaffin cell phenotype characterized by increased cell flattening, loss of neuritic processes, increased chromogranin A and tyrosine hydroxylase proteins, and decreased amounts of secretogranin II and neurofilaments. N-myc gene expression is upregulated by glucocorticoids; dexamethasone-treated N-type cells show significant (2.3- to 7.8-fold) increases in N-myc mRNA and protein steady-state levels. This effect is specific for glucocorticosteroids, is blocked by addition of the steroid receptor antagonist RU486, and involves direct activation of the N-myc promoter. These findings are the first to show that glucocorticoids upregulate N-myc expression in human neuroblastoma cells.
Ross
Robert A
RA
Department of Biological Sciences, Fordham University, Bronx, NY 10458, USA. rross@fordham.edu
Hein
Anne M
AM
Braca
John A
JA
Spengler
Barbara A
BA
Biedler
June L
JL
Scammell
Jonathan G
JG
D002454:Cell Differentiation / Q000187:drug effects; D019439:Chromaffin Cells / Q000166:cytology / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology*; D016259:Genes, myc; D006801:Humans; D015735:Mifepristone / Q000494:pharmacology; D009447:Neuroblastoma / Q000473:pathology*; D009490:Neurosecretory Systems / Q000166:cytology / Q000187:drug effects*; D011401:Promoter Regions, Genetic; D016271:Proto-Oncogene Proteins c-myc / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis
D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D015735:Mifepristone; D003907:Dexamethasone